biologic response modifiers ( brm ) such as interleukin-2 ( il-2 ) and gamma-interferon ( gamma ifn ) can augment preexisting or initiate new cytotoxic capacity of human lymphocytes against tumor cells .
C0021756
interleukin-2
C0086418
human